Your browser doesn't support javascript.
loading
Sputum microbiome profiles identify severe asthma phenotypes of relative stability at 12 to 18 months.
Abdel-Aziz, Mahmoud I; Brinkman, Paul; Vijverberg, Susanne J H; Neerincx, Anne H; Riley, John H; Bates, Stewart; Hashimoto, Simone; Kermani, Nazanin Zounemat; Chung, Kian Fan; Djukanovic, Ratko; Dahlén, Sven-Erik; Adcock, Ian M; Howarth, Peter H; Sterk, Peter J; Kraneveld, Aletta D; Maitland-van der Zee, Anke H.
Afiliação
  • Abdel-Aziz MI; Department of Respiratory Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands; Department of Clinical Pharmacy, Faculty of Pharmacy, Assiut University, Assiut, Egypt.
  • Brinkman P; Department of Respiratory Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Vijverberg SJH; Department of Respiratory Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Neerincx AH; Department of Respiratory Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Riley JH; Respiratory Therapeutic Unit, GlaxoSmithKline, Stockley Park, United Kingdom.
  • Bates S; Respiratory Therapeutic Unit, GlaxoSmithKline, Stockley Park, United Kingdom.
  • Hashimoto S; Department of Respiratory Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands; Department of Pediatric Respiratory Medicine, Emma Children's Hospital, Amsterdam UMC, Amsterdam, The Netherlands.
  • Kermani NZ; Data Science Institute, Imperial College London London, United Kingdom.
  • Chung KF; National Heart and Lung Institute, Imperial College London, and Royal Brompton and Harefield NHS Trust, London, United Kingdom.
  • Djukanovic R; NIHR Southampton Respiratory Biomedical Research Unit, Clinical and Experimental Sciences and Human Development and Health, University of Southampton, Southampton, United Kingdom.
  • Dahlén SE; Centre for Allergy Research, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Adcock IM; National Heart and Lung Institute, Imperial College London, and Royal Brompton and Harefield NHS Trust, London, United Kingdom.
  • Howarth PH; NIHR Southampton Respiratory Biomedical Research Unit, Clinical and Experimental Sciences and Human Development and Health, University of Southampton, Southampton, United Kingdom.
  • Sterk PJ; Department of Respiratory Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Kraneveld AD; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands; Institute for Risk Assessment Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.
  • Maitland-van der Zee AH; Department of Respiratory Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands; Department of Pediatric Respiratory Medicine, Emma Children's Hospital, Amsterdam UMC, Amsterdam, The Netherlands. Electronic address: a.h.maitland@amsterdamumc.nl.
J Allergy Clin Immunol ; 147(1): 123-134, 2021 01.
Article em En | MEDLINE | ID: mdl-32353491

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Asma / Escarro / Microbiota Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Egito

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Asma / Escarro / Microbiota Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Egito